Cohesin mutation sensitizes cancer cells to anti-PD-1 therapy through endogenous retrovirus-mediated PD-L1 upregulation
Yumin Han(Shanghai Jiao Tong University), Jing‐Yu Lang(The University of Texas MD Anderson Cancer Center), Zizhuo Chen(Shanghai Institute of Nutrition and Health), Ping Zhou(Harbin Medical University), Hong Zhu(Nanjing Agricultural University), Fangfei Peng(Shanghai Institute of Nutrition and Health), Jian Ding(Yuxi Normal University), Tingting Liu(Shanghai Jiao Tong University), Chen Qing(Kunming Medical University), Qian Dong(Qingdao University), Feng Jiang(Zhejiang Cancer Hospital), Xiangyin Kong(Shanghai Institute of Nutrition and Health), Yunqi Chang(Shanghai Institute of Nutrition and Health), Honggang Xiang(Second Military Medical University), Jiayan Shen(Hangzhou Normal University)
Cited by 1
Related Papers
Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors
|Cell|2018|271
APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis
|Journal of Clinical Investigation|2011|132
Loss-of-Function Mutations in the PRPS1 Gene Cause a Type of Nonsyndromic X-linked Sensorineural Deafness, DFN2
|The American Journal of Human Genetics|2009|124
Ferroptosis in Rheumatoid Arthritis: A Potential Therapeutic Strategy
|Frontiers in Immunology|2022|114